A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
2018 · Clinical Cancer Research · 268 citations
https://doi.org/10.1158/1078-0432.ccr-18-1912